Improvements With Guselkumab in Psoriatic Arthritis Seen Across All MDA Domains

(MedPage Today) -- At the American College of Rheumatology annual meeting, results from the phase IIIb COSMOS trial were presented that examined the association between patient- and physician-reported domains and minimal disease activity (MDA...
Source: MedPage Today Rheumatology - Category: Rheumatology Source Type: news